BRIEF-Bausch + Lomb confirms submission of Vesneo(TM) NDA to US FDA

Fri Jul 24, 2015 1:55am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

July 24 (Reuters) - Nicox Sa :

* Noted the confirmation by Valeant Pharmaceuticals International Inc's., wholly owned subsidiary, Bausch + Lomb, that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for Vesneo(TM)

* Nicox's advanced pipeline, partnered with Bausch + Lomb / Valeant, features Vesneo(TM), a pre-NDA candidate for glaucoma

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)